In the context of COVID-19, negative regulation of the fibrinolytic pathway due to elevated PAI-1, the main inhibitor of fibrinolysis, leads to excessive production of fibrinogen, promoting a prothrombotic hypercoagulable state and endothelial dysfunction via thrombus formation. This evidence concerns the gene SERPINE1 and COVID-19.